Pricing Log in Create free account

Adial Pharmaceuticals, Inc. (ADIL) vs CNS Pharmaceuticals, Inc. (CNSP)

Adial Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($8.3M and $7.9M). Across the 7 metrics below, CNS Pharmaceuticals, Inc. leads on 5 and Adial Pharmaceuticals, Inc. on 2.

Valuation

Metric ADIL CNSP Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 1.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.22 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (461.83%) (486.39%) (33.15%)
Free cash flow yield (68.29%) (40.54%) (25.50%)

Profitability

Metric ADIL CNSP Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (106.62%) (56.36%)
Return on assets (322.10%) (91.64%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADIL CNSP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 82.46% 92.34% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADIL CNSP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 5.86 4.72
Net debt to EBITDA 0.75 0.45 0.96

Dividend

Metric ADIL CNSP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADIL CNSP Biotechnology median
Market cap 8.25m 7.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack